Slay­back Pharma ap­points Dr Girish Jain as Global R&D Head

BioSpectrum (Asia) - - People News -

Slay­back Pharma LLC, a pri­vately held phar­ma­ceu­ti­cal re­search and de­vel­op­ment com­pany, has an­nounced the ap­point­ment of Dr Girish Jain as Se­nior Vice Pres­i­dent and Head of Global R&D. Dr Jain will be based out of Slay­back’s Hy­der­abad, In­dia office.

Dr Jain is a highly ac­com­plished sci­en­tist and a vet­eran in the field of Phar­ma­ceu­ti­cal Re­search and De­vel­op­ment. He is widely rec­og­nized in In­dia for his R&D lead­er­ship. He has suc­cess­fully led the de­vel­op­ment and fil­ing of more than 225 ANDAs with USFDA, across var­i­ous dosage forms and over 75 dif­fer­ent prod­ucts with Europe and Aus­tralia. He is also the lead in­ven­tor in scores of granted patents. His ex­pe­ri­ence strad­dles both the in­no­va­tive and generic phar­ma­ceu­ti­cal re­search space.

Dr Jain has had a stel­lar lead­er­ship track record in the in­dus­try. Prior to join­ing Slay­back, he was Pres­i­dent and Head of R&D at Alkem for the last four years. Ear­lier, he served for 10 years at Wock­hardt where he was the Se­nior Vice Pres­i­dent and Head of R&D in his last po­si­tion.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.